Aditya Singh

Aditya Singh, Alessandro Bay, Biswa Sengupta et al.

Deep neural networks have been shown to be highly miscalibrated. often they tend to be overconfident in their predictions. It poses a significant challenge for safety-critical systems to utilise deep neural networks (DNNs), reliably. Many recently proposed approaches to mitigate this have demonstrated substantial progress in improving DNN calibration. However, they hardly touch upon refinement, which historically has been an essential aspect of calibration. Refinement indicates separability of a network's correct and incorrect predictions. This paper presents a theoretically and empirically supported exposition reviewing refinement of a calibrated model. Firstly, we show the breakdown of expected calibration error (ECE), into predicted confidence and refinement under the assumption of over-confident predictions. Secondly, linking with this result, we highlight that regularization based calibration only focuses on naively reducing a model's confidence. This logically has a severe downside to a model's refinement as correct and incorrect predictions become tightly coupled. Lastly, connecting refinement with ECE also provides support to existing refinement based approaches which improve calibration but do not explain the reasoning behind it. We support our claims through rigorous empirical evaluations of many state of the art calibration approaches on widely used datasets and neural networks. We find that many calibration approaches with the likes of label smoothing, mixup etc. lower the usefulness of a DNN by degrading its refinement. Even under natural data shift, this calibration-refinement trade-off holds for the majority of calibration methods.

Aditya Singh, Akram Mohammed, Lokesh Chinthala et al.

Fever can provide valuable information for diagnosis and prognosis of various diseases such as pneumonia, dengue, sepsis, etc., therefore, predicting fever early can help in the effectiveness of treatment options and expediting the treatment process. This study aims to develop novel algorithms that can accurately predict fever onset in critically ill patients by applying machine learning technique on continuous physiological data. We analyzed continuous physiological data collected every 5-minute from a cohort of over 200,000 critically ill patients admitted to an Intensive Care Unit (ICU) over a 2-year period. Each episode of fever from the same patient were considered as an independent event, with separations of at least 24 hours. We extracted descriptive statistical features from six physiological data streams, including heart rate, respiration, systolic and diastolic blood pressure, mean arterial pressure, and oxygen saturation, and use these features to independently predict the onset of fever. Using a bootstrap aggregation method, we created a balanced dataset of 7,801 afebrile and febrile patients and analyzed features up to 4 hours before the fever onset. We found that supervised machine learning methods can predict fever up to 4 hours before onset in critically ill patients with high recall, precision, and F1-score. This study demonstrates the viability of using machine learning to predict fever among hospitalized adults. The discovery of salient physiomarkers through machine learning and deep learning techniques has the potential to further accelerate the development and implementation of innovative care delivery protocols and strategies for medically vulnerable patients.

Anirudh Kamath, Aditya Singh, Raj Ramnani et al.

Over 150,000 new people in the United States are diagnosed with colorectal cancer each year. Nearly a third die from it (American Cancer Society). The only approved noninvasive diagnosis tools currently involve fecal blood count tests (FOBTs) or stool DNA tests. Fecal blood count tests take only five minutes and are available over the counter for as low as \$15. They are highly specific, yet not nearly as sensitive, yielding a high percentage (25%) of false negatives (Colon Cancer Alliance). Moreover, FOBT results are far too generalized, meaning that a positive result could mean much more than just colorectal cancer, and could just as easily mean hemorrhoids, anal fissure, proctitis, Crohn's disease, diverticulosis, ulcerative colitis, rectal ulcer, rectal prolapse, ischemic colitis, angiodysplasia, rectal trauma, proctitis from radiation therapy, and others. Stool DNA tests, the modern benchmark for CRC screening, have a much higher sensitivity and specificity, but also cost \$600, take two weeks to process, and are not for high-risk individuals or people with a history of polyps. To yield a cheap and effective CRC screening alternative, a unique ensemble-based classification algorithm is put in place that considers the FIT result, BMI, smoking history, and diabetic status of patients. This method is tested under ten-fold cross validation to have a .95 AUC, 92% specificity, 89% sensitivity, .88 F1, and 90% precision. Once clinically validated, this test promises to be cheaper, faster, and potentially more accurate when compared to a stool DNA test.